IP Library Granted Patent US 10,465,248
Granted Patent B2
US 10,465,248 · App. 14/966,617 · Granted Nov 5, 2019

Method of characterizing ZDHHC1 DNA

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,465,248
App. No.
14/966,617
Granted
Nov 5, 2019
Kind
B2
Abstract

Provided herein is technology relating compositions and methods for detecting tissue cell-specific DNA, such as epithelial cell-specific DNA, in blood or blood products from a subject. The technology also relates to use of tissue cell-specific DNAs as internal controls for methylation assays.

Claims (17)

1. A method of characterizing blood or blood product, comprising:

a) providing a blood or blood product sample from a subject;

b) assaying said sample to detect the presence of ZDHHC1 epithelial cell-specific DNA,

wherein said assaying comprises:

i) treating DNA from said sample with a bisulfite reagent to create bisulfite-converted ZDHHC1 DNA comprising the nucleotide sequence of SEQ ID NO:33;

ii) amplifying a region of said bisulfite converted DNA using a pair of primers complementary to primer binding sites within SEQ ID NO:27 and its complement, wherein in said amplifying, said primers hybridize to said primer binding sites and are extended to amplify a region of SEQ ID NO:27 bounded by the primer binding sites to produce amplified product; and

iii) detecting said amplified product.

2. The method of claim 1 , wherein said blood product is plasma.

3. The method of claim 1 , wherein said detecting comprises detecting hybridization of the amplified product to a detection probe.

4. The method of claim 3 , wherein said detection probe comprises a reporter molecule.

5. The method of claim 4 , where said reporter molecule comprises a fluorophore.

6. The method of claim 3 , wherein said detection probe comprises a flap sequence.

7. The method of claim 3 , wherein said detecting hybridization of the amplified product to said detection probe comprises use of a FRET cassette.

8. The method of claim 3 , wherein said detecting hybridization of the amplified product to said detection probe comprises use of a FEN-1 endonuclease.

9. The method of claim 1 , wherein assaying said sample comprises measuring an amount of ZDHHC1 epithelial cell-specific DNA in the blood or blood product sample.

10. The method of claim 9 , wherein said measuring comprises a quantitative amplification reaction.

11. The method of claim 10 , wherein the quantitative amplification reaction comprises real-time fluorescence detection.

Assignments (4)
PATENT SECURITY AGREEMENT Recorded Jan 14, 2025
From: EXACT SCIENCES CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069898/0249 →
MERGER Recorded Jan 14, 2022
From: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
To: EXACT SCIENCES CORPORATION
Reel/Frame 058738/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2017
From: EXACT SCIENCES CORPORATION
To: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
Reel/Frame 044119/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2015
From: LIDGARD, GRAHAM P.; ALLAWI, HATIM T.
To: EXACT SCIENCES CORPORATION
Reel/Frame 037302/0434 →